Gene Editing in Cancer Therapy

Abstract

The site-specific modification of an existing gene is known as gene editing. A section of DNA must be cut with an endonuclease (such as the CRISPR-Cas9 system) before the two severed ends are brought together, frequently with a new or improved sequence inserted between them. Somatic cell gene editing can be helpful in a variety of clinical contexts, and some preliminary preclinical and clinical trials have been carried out. Extremely high levels of precision are required for DNA recognition, excision, and repair; issues with publishing integrity must be resolved. Germline editing utilizing eggs, sperm, or embryos raises ethical concerns.

Authors and Affiliations

Gloria Nataly Pérez Serrano,Alejandra Jeraldine Gonzalez Barajas

Keywords

Related Articles

Improve Patient–Care Provider Interactions and Shortage of Staff during Covid 19 by Implementing Person–Center Proposal Daily Round

Objective:evaluate the improvement of Patient –Care provider interactions by implementing a person –center proposal daily round ensured by trained non-medical staff for patients admitted in wards. Design:prospective com...

Thoracic Spine Deformity Post Tetanus: A Case Report of Tetanus Post Circumcision

Tetanus is caused by clostridium tetani bacteria through skin breach. The tetanus is characterized by tonic contraction and muscle spasm which can cause vertebral fracture in some patients.we are reporting a young male p...

Response to Adjuvant Therapy of Granulomatous Lymphadenitis: Evidence from High Burden Country

Introduction: A granulomatous lymphadenitis is a form of inflammation of the lymph nodes that are often found. Until now, effective treatment of granulomatous lymphadenitis is still inconsistent, namely between surgical...

A Review of the Literature on the Porcelain Gallbladder

Porcelain gallbladder is a rare and potentially serious condition characterized by calcification of the gallbladder wall. Chronic inflammation and bile flow obstruction are thought to be important factors in its pathoge...

Primary Ovarian Diffuse Large B-Cell Lymphoma in a 34 year old Lady :A Case Report

Involvement of the ovary by malignant lymphoma is well known as the late manifestation of disseminated disease. Primary ovarian lymphoma(POL) is extremely rare , accounting for 0.5 % of all NHLs and 1.5% of all mal...

Download PDF file
  • EP ID EP733668
  • DOI 10.47191/ijmscrs/v2-i10-22
  • Views 30
  • Downloads 0

How To Cite

Gloria Nataly Pérez Serrano, Alejandra Jeraldine Gonzalez Barajas (2022). Gene Editing in Cancer Therapy. International Journal Of Medical Science And Clinical Research Studies, 2(10), -. https://europub.co.uk./articles/-A-733668